Cargando…
Antibiotic resistance status and its costs in hematological patients: A two-year analysis
BACKGROUND: Most frequently, empirical antibiotic therapy is immediately administered for patients with febrile neutropenia (FN). In this study, its aim was to assess the antibiotic resistance status and the cost of antibacterial agents in FN patients associated with hematological malignancies. METH...
Autor principal: | Gedik, Habip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Babol University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686306/ https://www.ncbi.nlm.nih.gov/pubmed/29201318 http://dx.doi.org/10.22088/cjim.8.4.276 |
Ejemplares similares
-
The expenditures related to the use of antifungal drugs in patients with hematological cancers: a cost analysis
por: Gedik, Habip
Publicado: (2015) -
Bloodstream infections in patients with hematological malignancies: which is more fatal – cancer or resistant pathogens?
por: Gedik, Habip, et al.
Publicado: (2014) -
Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage
por: Gedik, Habip, et al.
Publicado: (2014) -
Community-acquired intracranial suppurative infections: A 15-year report
por: Yıldırmak, Taner, et al.
Publicado: (2014) -
Etiological causes of pancytopenia: A report of 137 cases
por: Yokuş, Osman, et al.
Publicado: (2016)